Linked research, clinical, and regulatory source pathways.
Company profile
About Coreline Soft Co., Ltd
Coreline Soft Co., Ltd. is a medical AI company specializing in developing automated diagnostic solutions for healthcare professionals. The company focuses on detecting diseases before symptoms appear, with particular expertise in thoracic imaging analysis. Their flagship product, aview LCS Plus, simultaneously detects and analyzes the 'Big 3' chest diseases: lung cancer (through pulmonary nodule detection), chronic obstructive pulmonary disease (COPD), and coronary artery calcification (CAC) from chest CT scans. Beyond thoracic imaging, Coreline Soft offers solutions for interstitial lung disease pattern analysis, intracranial hemorrhage diagnosis, automatic blood vessel analysis, and radiation therapy contouring. The company also provides medical 3D printing solutions, research assistance tools, and data pseudonymization servers. Coreline Soft's technology is designed to automate workflows and improve efficiency for radiologists and healthcare providers. The company has achieved regulatory clearances across multiple markets including FDA (USA), CE (Europe), PMDA (Japan), TFDA (Taiwan), TGA (Australia), and others. Coreline Soft actively partners with global healthcare firms and participates in international lung cancer screening projects, particularly in Germany and Australia. Their solutions are utilized in globally renowned research projects and clinical validation programs.
Company description Coreline Soft Co., Ltd official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Coreline Soft Co., Ltd?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- COPD
- coronary artery calcification
- emphysema
- interstitial lung abnormalities
- interstitial lung disease
- intracranial hemorrhage
- lung cancer
- pneumonia
- pulmonary nodules
- sarcopenia
Who it serves
- Cancer Screening Programs
- Health Systems
- Radiology Practices
- Research Institutions
Deployment & integration
Deployment information is currently being developed.
Recorded integration context: INFINITT, PACS systems, radiology workflow systems.
Geographic context
MarketsAustralia · Brazil · Canada · Europe · Germany · Italy · Japan · Korea · Singapore · Taiwan · United States
Company sourceOfficial website
Company milestones
Platform expansion
U.S. Clinical Validation Program launch (2026), partnership with Mint Medical for lung cancer screening (2026), renewed partnership with Italy's National Cancer Institute (2026), Germany lung cancer screening reimbursement set for 2026, partnership with Raya Diagnostics for European expansion (2026), AVIEW LCS granted Conditional New Health Technology Status in Korea (2026), embedded zero-click AI workflow with INFINITT (2026)
Partnerships
Recorded partners
- INFINITT
- Italy's National Cancer Institute
- Mint Medical
- Raya Diagnostics
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
AVIEW Lung Nodule CADK251203 · 510k · Dec 3, 2025
AVIEWK243689 · 510k · Mar 19, 2025
AVIEW CACK243696 · 510k · Feb 14, 2025
AVIEW CACK233211 · 510k · Mar 29, 2024
AVIEW Lung Nodule CADK221592 · 510k · Feb 24, 2023
AVIEWK214036 · 510k · Dec 23, 2022
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
automated detection of small lung nodules
early lung cancer detection
simultaneous analysis of Big 3 chest diseases
comprehensive thoracic assessment
workflow automation and efficiency improvement
radiology practice optimization
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Coreline Soft Co., Ltd
Recent articles published on Coreline Soft Co., Ltd's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.